Burzynski Research Company Executives
| BZYR Stock | USD 0.04 0.01 28.57% |
Burzynski Research employs about 6 people. The company is managed by 2 executives with a total tenure of roughly 24 years, averaging almost 12.0 years of service per executive, having 3.0 employees per reported executive. Discussion of Burzynski Research's management performance can provide insight into the enterprise performance.
| Stanislaw Burzynski Chairman Chairman of the Board and Presidentident |
Burzynski |
Burzynski Research Management Team Effectiveness
The company has return on total asset (ROA) of (127.6631) % which means that it has lost $127.6631 on every $100 spent on assets. This is way below average. Burzynski Research's management efficiency ratios could be used to measure how well Burzynski Research manages its routine affairs as well as how well it operates its assets and liabilities.Burzynski Research Workforce Comparison
Burzynski Research is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,346. Burzynski Research adds roughly 6.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Burzynski Research Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Burzynski Research Price Series Summation is a cross summation of Burzynski Research price series and its benchmark/peer.
Burzynski Research Notable Stakeholders
A Burzynski Research stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Burzynski Research often face trade-offs trying to please all of them. Burzynski Research's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Burzynski Research's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stanislaw Burzynski | Chairman of the Board and Presidentident | Profile | |
| Patryk Goscianski | Treasurer, Secretary | Profile |
About Burzynski Research Management Performance
The success or failure of an entity such as Burzynski Research often depends on how effective the management is. Burzynski Research management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Burzynski management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Burzynski management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States.
Burzynski Research Workforce Analysis
Traditionally, organizations such as Burzynski Research use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Burzynski Research within its industry.Burzynski Research Manpower Efficiency
Return on Burzynski Research Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 162.8K | |
| Net Loss Per Executive | 488.3K |
Additional Tools for Burzynski Pink Sheet Analysis
When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.